TAIWAN · TWSE / TPEx
GWOXI
國璽幹細胞 · 6704 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$23.101 month +13.8% · 1 year -21.7%
Directors and supervisors hold20,331,79719.2% of shares issued
Of which pledged0.0%0
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 莊明熙 | Chairman | 2,163,186 | 2,446,071 | 2.31% | — | — |
| 羅貴連 | Director | 7,500,000 | 7,500,000 | 7.08% | — | — |
| 康錫東 | Director | 1,705,396 | 1,911,396 | 1.80% | — | 1,153,578 |
| 邱淳芬 | Director · President | 940,000 | 1,040,000 | 0.98% | — | — |
| 羅苓 | Director | 5,039,227 | 5,039,227 | 4.76% | — | 129,000 |
| 陳柏儒 | Director | 775,000 | 767,000 | 0.72% | — | — |
| 賀力行 | Director | 1,468,103 | 1,628,103 | 1.54% | — | 250,300 |
| 余士迪 | Independent director | — | 0 | — | — | — |
| 吳貞宜 | Independent director | — | 0 | — | — | — |
| 戴裕庭 | Independent director | — | 0 | — | — | — |
| 林珀丞 | Manager | — | 292,558 | 0.28% | — | — |
| 林宛螢 | Manager | — | 47,000 | 0.04% | — | 6,325 |
| 李邦瑜 | Chief financial officer · Chief accountant | — | 10,000 | 0.01% | — | — |